rdf:type |
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0030705,
umls-concept:C0332293,
umls-concept:C0439828,
umls-concept:C0443196,
umls-concept:C0521115,
umls-concept:C0546837,
umls-concept:C0936012,
umls-concept:C1514695,
umls-concept:C1550147,
umls-concept:C1554127
|
pubmed:issue |
5
|
pubmed:dateCreated |
2004-3-30
|
pubmed:abstractText |
To analyze the relative contributions of uniformly collected pretreatment patient- and tumor-related variables to survival and to identify the terminal nodes via recursive partitioning analysis (RPA) that could be used as a stratification variable for future Phase III trials.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0360-3016
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1405-10
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15050316-Adenocarcinoma,
pubmed-meshheading:15050316-Adult,
pubmed-meshheading:15050316-Aged,
pubmed-meshheading:15050316-Aged, 80 and over,
pubmed-meshheading:15050316-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15050316-Carcinoma, Squamous Cell,
pubmed-meshheading:15050316-Cisplatin,
pubmed-meshheading:15050316-Clinical Trials, Phase III as Topic,
pubmed-meshheading:15050316-Combined Modality Therapy,
pubmed-meshheading:15050316-Esophageal Neoplasms,
pubmed-meshheading:15050316-Female,
pubmed-meshheading:15050316-Fluorouracil,
pubmed-meshheading:15050316-Humans,
pubmed-meshheading:15050316-Male,
pubmed-meshheading:15050316-Middle Aged,
pubmed-meshheading:15050316-Prognosis
|
pubmed:year |
2004
|
pubmed:articleTitle |
Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials.
|
pubmed:affiliation |
Department of Radiation Oncology, The University of Texas Health Science Center, San Antonio, TX 78229-3900, USA. cthomas@saci.org
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|